Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Search results for

There are 42,989 results that match your search.42,989 results
  • A year on the from the Alice decision, many IP practitioners feel that Section 101 is in a state of ruin. Speakers at the BIO International Convention put forward proposals for Congress to overhaul the much-maligned section
  • The figures in the year since the Supreme Court’s Alice ruling reveal that the district courts, Federal Circuit and PTAB are invalidating patents on 101 grounds at very high rates
  • No fewer than four reports addressing open innovation have landed in my Inbox in the past couple of weeks. Is this just a coincidence, or is there a trend?
  • Speakers at the BIO International Convention were dismayed by the Federal Circuit’s decision that a Sequenom patent was invalid. But they were hopeful that Judge Linn's concurring opinion criticising the Mayo framework pointed the way to a Supreme Court appeal
  • The consultation on the court fees, SME support and recoverable costs for the Unified Patent Court runs until July 31 and provides an opportunity for anyone to help shape this important aspect of the proposed new patent system in Europe. A series of events in the UK over the next month will provide more information
  • In-house counsel speakers at Managing IP’s Women in IP network Forum in New York last week shared tops on litigating technology, dealing with NPEs and preparing for European patent reform
  • The total number of post-grant review petitions filed with the Patent Trial and Appeal Board jumped to eight in May. The month also included 145 inter partes review petitions and an important ruling on estoppel by the Board
  • Intellectual Ventures II has sued Canon for infringing digital imaging patents, the first lawsuits from the fund since it sued two insurers in January
  • After previously being included on the fringes of discussion around US patent reform, Patent Trial and Appeal Board proceedings are now one of legislators' main focuses. The rejigged PATENT Act has been branded “a PTAB reform bill” by one observer
  • Kyle Bass has filed another IPR petition targeting a pharma company, taking aim again at the Vimovo pain reliever, while IPO has passed a resolution opposing the use of post-grant proceedings to manipulate the market
181
of
4299